For: | Kennelly RP, Murphy B, Larkin JO, Mehigan BJ, McCormick PH. Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma. World J Gastrointest Oncol 2016; 8(8): 623-628 [PMID: 27574555 DOI: 10.4251/wjgo.v8.i8.623] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i8/623.htm |
Number | Citing Articles |
1 |
Ana Soler-Cardona, Agnes Forsthuber, Katharina Lipp, Stefanie Ebersberger, Magdalena Heinz, Klaudia Schossleitner, Elisabeth Buchberger, Marion Gröger, Peter Petzelbauer, Christoph Hoeller, Erwin Wagner, Robert Loewe. CXCL5 Facilitates Melanoma Cell–Neutrophil Interaction and Lymph Node Metastasis. Journal of Investigative Dermatology 2018; 138(7): 1627 doi: 10.1016/j.jid.2018.01.035
|
2 |
Ross D. Dolan, Stephen T. McSorley, Paul G. Horgan, Donald C. McMillan. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer. Medicine 2018; 97(13): e0185 doi: 10.1097/MD.0000000000010185
|
3 |
Marta Climent, Éanna J. Ryan, Áine Stakelum, Yi Ling Khaw, Ben Creavin, Angus Lloyd, Dalal Alhassan, Helen M. Mohan, Rory Kennelly, Kieran Sheahan, Des C. Winter. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer. International Journal of Colorectal Disease 2019; 34(6): 1069 doi: 10.1007/s00384-019-03274-6
|
4 |
Nikoletta Dimitriou, Evangelos Felekouras, Ioannis Karavokyros, Andreas Alexandrou, Emmanuel Pikoulis, John Griniatsos. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5042-x
|